Group One Trading
TVRD

Group One Trading’s Tvardi Therapeutics TVRD Stock Holding History

Group One Trading’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$430 – 9044
2025
Q4 		$430 Hold
100
– – ﹤0.01% 7826
2025
Q3 		$3.9K Buy
+100
New +$2.85K ﹤0.01% 7662
2024
Q4 		– Sell
-142
Closed -$1.57K – 8101
2024
Q3 		$1.57K Sell
142
-2
-1% -$23 ﹤0.01% 6204
2024
Q2 		$1.34K Buy
+144
New +$3.44K ﹤0.01% 6306
2024
Q1 		– Sell
-19
Closed -$520 – 8126
2023
Q4 		$520 Sell
19
-278
-94% -$11.5K ﹤0.01% 7087
2023
Q3 		$18K Buy
297
+111
+60% +$10.4K ﹤0.01% 5960
2023
Q2 		$19K Sell
186
-167
-47% -$23K ﹤0.01% 6023
2023
Q1 		$62.4K Sell
353
-97
-22% -$32.5K ﹤0.01% 4690
2022
Q4 		$174K Sell
450
-1,469
-77% -$558K ﹤0.01% 3974
2022
Q3 		$647K Sell
1,919
-400
-17% -$145K ﹤0.01% 2974
2022
Q2 		$762K Buy
2,319
+275
+13% +$96.5K ﹤0.01% 3009
2022
Q1 		$894K Sell
2,044
-1,348
-40% -$553K ﹤0.01% 3199
2021
Q4 		$1.49M Buy
3,392
+923
+37% +$464K ﹤0.01% 2923
2021
Q3 		$1.37M Buy
2,469
+269
+12% +$135K ﹤0.01% 3054
2021
Q2 		$1.13M Buy
2,200
+892
+68% +$565K ﹤0.01% 3270
2021
Q1 		$1.02M Sell
1,308
-1,031
-44% -$706K ﹤0.01% 3194
2020
Q4 		$1.27M Buy
2,339
+803
+52% +$421K ﹤0.01% 2429
2020
Q3 		$704K Sell
1,536
-8
-0.5% -$4.65K ﹤0.01% 2536
2020
Q2 		$951K Sell
1,544
-114
-7% -$63K ﹤0.01% 2067
2020
Q1 		$789K Sell
1,658
-573
-26% -$311K 0.01% 1708
2019
Q4 		$1.29M Buy
2,231
+1,009
+83% +$708K 0.01% 1666
2019
Q3 		$804K Buy
1,222
+105
+9% +$87.3K 0.01% 1929
2019
Q2 		$864K Buy
1,117
+892
+396% +$627K 0.01% 1693
2019
Q1 		$159K Sell
225
-1,139
-84% -$682K ﹤0.01% 2867
2018
Q4 		$638K Sell
1,364
-811
-37% -$523K 0.01% 1836
2018
Q3 		$1.88M Sell
2,175
-2,206
-50% -$1.59M 0.01% 1216
2018
Q2 		$3.02M Buy
4,381
+3,489
+391% +$1.77M 0.03% 833
2018
Q1 		$397K Sell
892
-1,514
-63% -$734K ﹤0.01% 2236
2017
Q4 		$1.06M Sell
2,406
-4,105
-63% -$1.87M 0.01% 1655
2017
Q3 		$3.21M Sell
6,511
-2,667
-29% -$1.34M 0.03% 755
2017
Q2 		$5.08M Buy
9,178
+7,825
+578% +$4.97M 0.05% 439
2017
Q1 		$896K Sell
1,353
-108
-7% -$57.7K 0.01% 1409
2016
Q4 		$489K Sell
1,461
-672
-32% -$216K ﹤0.01% 1788
2016
Q3 		$641K Buy
2,133
+2,044
+2,297% +$443K 0.01% 1626
2016
Q2 		$15K Buy
89
+28
+46% +$6.1K ﹤0.01% 3921
2016
Q1 		$14K Sell
61
-145
-70% -$43.3K ﹤0.01% 3903
2015
Q4 		$125K Buy
206
+137
+199% +$75.2K ﹤0.01% 2842
2015
Q3 		$36K Sell
69
-100
-59% -$66.9K ﹤0.01% 3737
2015
Q2 		$74K Buy
+169
New +$65.3K ﹤0.01% 3298

Other funds holding TVRD

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWAM
Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return

Group One Trading's TVRD Position: Q1 2026 in Review

Group One Trading increased its Tvardi Therapeutics (TVRD) stake by 88% in Q1 2026, buying an estimated $392 and bringing the position to 214 shares worth $681. The position accounts for ﹤0.01% of the portfolio, ranked #7278.

Group One Trading first reported a position in TVRD in Q2 2015 and has held it in 33 quarters since. The position peaked at $1.77M in Q4 2019. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.

  • Group One Trading held 214 shares of Tvardi Therapeutics worth $681 as of Q1 2026.
  • Group One Trading bought 100 Tvardi Therapeutics shares in Q1 2026, an estimated $392.
  • Tvardi Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7278 holding.
  • Group One Trading first reported a position in Tvardi Therapeutics in Q2 2015 and has held it in 33 quarters since.
  • Group One Trading's Tvardi Therapeutics position peaked at $1.77M in Q4 2019.
  • 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.